Our Legacy in the U.S.

Daiichi Sankyo is Chair of the Centennial Host Committee for the 2012 National Cherry Blossom Festival.

Scientific breakthroughs helping patients

DSI’s comprehensive portfolio, including our cardiovascular and metabolic therapies, offers innovative treatments for a wide range of diseases.

Continuing Medical Education

By funding Continuing Medical Education programs, DSI helps healthcare professionals stay up-to-date

Reporting adverse reactions

Please report any adverse reactions to our products to the Daiichi Sankyo Contact Center at 1-877-4 DS-PROD (1-877-437-7763). Or to report negative side effects of prescription drugs to the FDA visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Contact Us

U.S. Corporate Headquarters

Daiichi Sankyo, Inc.

Two Hilton Court

Parsippany, NJ 07054

Phone: 973-944-2600

Fax: 973-944-2645

Daiichi Sankyo Pharma Development

399 Thornall Street

Edison, NJ 08837

Phone: 732-590-5000

Learn More

Daiichi Sankyo Call Center

1-877-437-7763

For healthcare providers and patients with questions or concerns about our products.

Patient Assistance Program

Daiichi Sankyo Open Care Program

PO Box 8409

Somerville, NJ 08876

Phone: 1-866-268-7327

Application

Supplier Diversity Program

Daiichi Sankyo, Inc.

Atln: Supplier Diversity Department

Two Hilton Court

Parsippany, NJ 07054

Phone: 1-877-726-5961 ext. 80989

Fax: 973-630-2808

smallbusinessplan@dsi.com

Office of Certified Continuing Medical Education

Daiichi Sankyo, Inc.

Atln: OCME

Two Hilton Court

Parsippany, NJ 07054

Phone: 973-944-2599

Fax: 973-944-2267

OCME@dsi.com

Compliance Hotline

Call 1-877-48-ALERT (1-877-482-5378) with questions on compliance or ethical issues or to report unethical or questionable activity.

Reporting Adverse Reactions

Please report any adverse reactions to our products to the Daiichi Sankyo Contact Center at 1-877-4 DS-PROD (1-877-437-7763). Or to report negative side effects of prescription drugs to the FDA visit www.fda.gov/medwatch or call 1-800-FDA-1088.